Duvelisib with docetaxel for patients with anti-PD-1 refractory, recurrent or metastatic head and neck squamous cell carcinoma.
Hanna GJ, Oakley LB, Shi R, ONeill A, Shin KY, Scarfo N, Sehgal K, Dennis MJ, Quinn N, Jo VY, Wong K, Shvyrkova A, Kushnarev V, Shanthappa BU, Tkachuk A, Kryukov K, Sarachakov A, Svekolkin V, Lennerz J, Waters S, Haddad RI.
Hanna GJ, et al. Among authors: haddad ri.
Clin Cancer Res. 2024 Dec 3. doi: 10.1158/1078-0432.CCR-24-2262. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 39625478